Ohcanbohtosat - Alejandro Moreno‐Koehler

  • Čájehuvvo 1 - 2 / 2
Aiddostahte ozu
  1. 1
    Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients

    Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients Dahkki Kate Sully, Andrew Trigg, Nicola Bonner, Alejandro Moreno‐Koehler, Claire Trennery, Nina Shah, Emre Yücel, Sumeet Panjabi, Kim Cocks

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1

    First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1 Dahkki Martin Reck, Tudor‐Eliade Ciuleanu, Jong Seok Lee, Michael Schenker, Clarisse Audigier-Valette, Bogdan Żurawski, Helena Linardou, Gregory A. Otterson, Pamela Salman, Makoto Nishio, Emmanuel de la Mora Jimenez, Krysztof Lesniewski-Kmak, István Albert, Samreen Ahmed, Konstantinos Syrigos, John R. Penrod, Yong Yuan, Steven I. Blum, Faith E. Nathan, Xiaowu Sun, Alejandro Moreno‐Koehler, Fiona Taylor, Kenneth J. O’Byrne

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: